Press Release

Global Tissue Imaging Market to Exceed USD 14 Billion by 2030, Registering a CAGR of Around 9.5% During 2025-30

The Global Tissue Imaging Market size was valued at USD10.3 Billion in 2023 & is expected to reach USD14.3 Billion by 2030. The market is expected to grow at a CAGR of 9.5% during the forecast period of 2025-30, cites MarkNtel Advisors in the recent research report.

Diseases like cancer & CVDs have prompted healthcare facilities across countries to adopt advanced diagnostic technologies like tissue imaging to provide patients with precise & accurate diagnoses of diseases. Further, throughout the world, there has been a significant presence of obese & overweight individuals who are at risk for diseases like cancer & CVDs. These individuals realizing the risk have started visiting hospitals, diagnostic laboratories, and other medical facilities to get appropriate diagnoses for diseases. As a result, the adoption of Tissue Imaging products has witnessed a rise.

The limited effectiveness of conventional treatments for diseases such as cancer and Parkinson’s has prompted researchers to develop customized therapies that have improved efficacy, based on individual patient characteristics. This shift towards personalized medicine has increased the demand for tissue imaging technologies, allowing researchers to understand patients' genetic information and develop more effective targeted therapies. As a result, the Global Market for Tissue Imaging has been growing.

Further, governments across nations have been taking valuable steps to boost the healthcare infrastructure of their country. This resulted in increased investments in the construction of new hospitals as well as the upgradation of existing facilities through the adoption of advanced healthcare technologies like tissue imaging. Moreover, various government & non-government initiatives have motivated individuals especially those involved in smoking and alcohol consumption, and who have a family history of diseases like breast cancer, HIV, etc. to go for routine diagnosis for early detection of diseases. This improves the survival rates of patients and eventually boosts the demand for tissue imaging products. Additionally, there has been a growing popularity of digital pathology due to its ability to facilitate remote consultations, thereby improving access to specialized pathology services, especially in underserved & remote areas. This propels the overall market for tissue imaging, further states the research report, “Global Tissue Imaging Market Analysis, 2024.”

 

Global Tissue Imaging Market Segmentation Analysis

Flow Cytometry Segment Held a Considerable Market Share of the Global Tissue Imaging Market

Based on the technology segment, the market is further bifurcated into Mass Spectroscopy, Immunohistochemistry (IHC), Flow Cytometry, Digital Pathology, In-Situ Hybridization, Immunofluorescence, and Others (Confocal Microscopy, Electron Microscopy, etc.).

The flow cytometry segment had a considerable market share in the Global Tissue Imaging Market. HIV & cancer rates have prompted healthcare facilities to adopt diagnostic technologies like flow cytometry. It allows for precise & accurate diagnosis of diseases at early stages. Healthcare professionals thereby provide patients with the right treatment, improving the chances of patient survival and reducing mortality rates.

Further, governments in many countries have been supporting biomedical research programs with appropriate investments & funding. This allowed researchers to get advanced tissue imaging technologies like flow cytometry to perform quality research & serve the human population. Moreover, the integration of AI, automation, and other advancements have improved the efficiency of flow cytometry products in terms of diagnosis & research, thereby fueling its adoption by healthcare providers & researchers.    

North America to Dominate the Global Tissue Imaging Market Growth

North America is expected to hold a significant market share of the Global Cancer Informatics Market. This is due to the rising geriatric population which has escalated the rates of diseases like cancer & CVDs. Also, rates of neurological diseases like Alzheimer's & Parkinson’s disease have been alarming in the region. As a result, demand for tissue imaging diagnostic products has been increasing in the region to improve the diagnosis & monitoring of such diseases.

Also, recognizing the high rates of neurological diseases, disorders, and illnesses, governments of the US, Canada, and Mexico have been making significant investments to boost research programs aimed at finding new treatments for neurological diseases. Due to this, there has been a rise in the adoption of tissue imaging technologies to study every aspect of brain diseases. Hence, the market for Tissue Imaging has been expanding in the North America region.  Moreover, these countries have a highly developed healthcare ecosystem where healthcare providers always seek state of art advanced healthcare technologies like tissue imaging to improve patient health outcomes.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Abbott Laboratories, Roche Holding AG, Bio-Rad Laboratories, Bio SB, Inc., Agilent Technologies, Olympus Corporation, Abcam Plc, Biocare Medical LLC, Sakura Finetek., LifeSpan BioSciences, Inc., Hamamatsu Photonics K.K., Danaher Corporation, Merck KGaA., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, etc. are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Market Size- By Value, Forecast Numbers, Segmentation, Market Shares)?
2. What are the market trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across the region?
6. How have the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?